Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174 |
filingDate |
2001-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe663b3a3bc0c7a3b040b7e22447ec01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afe95e30992779d4f68bc4fe28dbe3c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eda4bf9da24d002f992951161560036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c8bed21e1f62fcee2fd3656fe746f4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8312a8c22b7369e8695e68fa87f049e6 |
publicationDate |
2001-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2001039255-A1 |
titleOfInvention |
Use of alpha1A adrenoceptor agonists with alpha1B and alpha1D antagonism for the treatment of stress urinary incontinence |
abstract |
The following disclosure relates to a method of treating incontinence with a compound having a specific α 1A adrenoceptor profile. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02100414-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8778897-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004242547-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003220319-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8324178-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6852726-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9364462-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010113377-A1 |
priorityDate |
2000-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |